These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 7033385

  • 1. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA, Showell HJ, Freer RJ, Becker EL.
    J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
    [Abstract] [Full Text] [Related]

  • 2. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA, Becker EL.
    J Immunol; 1982 Feb; 128(2):963-8. PubMed ID: 7054297
    [Abstract] [Full Text] [Related]

  • 3. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H, Gallin JI.
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [Abstract] [Full Text] [Related]

  • 4. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
    Keller HU, Wissler JH, Damerau B.
    Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
    [Abstract] [Full Text] [Related]

  • 5. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
    Mackin WM, Huang CK, Becker EL.
    J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
    [Abstract] [Full Text] [Related]

  • 6. Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.
    Fletcher MP, Seligmann BE, Gallin JI.
    J Immunol; 1982 Feb; 128(2):941-8. PubMed ID: 6274963
    [Abstract] [Full Text] [Related]

  • 7. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
    Beswick PH, Kay AB.
    Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
    [Abstract] [Full Text] [Related]

  • 8. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
    Marasco WA, Becker EL, Oliver JM.
    Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
    [Abstract] [Full Text] [Related]

  • 9. Actin polymerization induced by chemotactic peptide and concanavalin A in rat neutrophils.
    Rao KM, Varani J.
    J Immunol; 1982 Oct; 129(4):1605-7. PubMed ID: 6286771
    [Abstract] [Full Text] [Related]

  • 10. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
    Borish L, O'Reilly D, Klempner MS, Rocklin RE.
    J Immunol; 1986 Sep 15; 137(6):1897-903. PubMed ID: 3018081
    [Abstract] [Full Text] [Related]

  • 11. Formyl peptide chemotaxis receptors on the rat neutrophil: experimental evidence for negative cooperativity.
    Marasco WA, Feltner DE, Ward PA.
    J Cell Biochem; 1985 Sep 15; 27(4):359-75. PubMed ID: 2987275
    [Abstract] [Full Text] [Related]

  • 12. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
    Jesaitis AJ, Naemura JR, Painter RG, Schmitt M, Sklar LA, Cochrane CG.
    J Cell Biochem; 1982 Sep 15; 20(2):177-91. PubMed ID: 6302115
    [Abstract] [Full Text] [Related]

  • 13. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
    Harvath L, Aksamit RR.
    J Immunol; 1984 Sep 15; 133(3):1471-6. PubMed ID: 6086757
    [Abstract] [Full Text] [Related]

  • 14. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
    Dentino AR, Raj PA, De Nardin E.
    Arch Biochem Biophys; 1997 Jan 15; 337(2):267-74. PubMed ID: 9016822
    [Abstract] [Full Text] [Related]

  • 15. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L, Yancey KB, Katz SI.
    J Immunol; 1986 Aug 15; 137(4):1305-11. PubMed ID: 3016092
    [Abstract] [Full Text] [Related]

  • 16. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
    Fu H, Bylund J, Karlsson A, Pellmé S, Dahlgren C.
    Immunology; 2004 Jun 15; 112(2):201-10. PubMed ID: 15147563
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of chemotactic factor-induced neutrophil responsiveness by arachidonic acid.
    Naccache PH, Molski TF, Volpi M, Mackin WM, Becker EL, Sha'afi RI.
    J Cell Physiol; 1983 Jun 15; 115(3):243-8. PubMed ID: 6406520
    [Abstract] [Full Text] [Related]

  • 18. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes.
    Lohr KM, Snyderman R.
    J Immunol; 1982 Oct 15; 129(4):1594-9. PubMed ID: 6286769
    [Abstract] [Full Text] [Related]

  • 19. Leucoattractants enhance complement receptors on human phagocytic cells.
    Kay AB, Glass EJ, Salter DM.
    Clin Exp Immunol; 1979 Nov 15; 38(2):294-9. PubMed ID: 527263
    [Abstract] [Full Text] [Related]

  • 20. Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors.
    Weisbart RH, Golde DW, Gasson JC.
    J Immunol; 1986 Dec 01; 137(11):3584-7. PubMed ID: 3491142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.